Predictive Modeling of Mortality in Polymyositis/Dermatomyositis Patients with Interstitial Lung Disease Based on Combination of Serum Myositis-Specific Autoantibodies and Conventional Biomarkers

被引:0
|
作者
Gono, Takahisa [1 ]
Masui, Kenichi [2 ]
Kawaguchi, Yasushi [3 ]
Ikeda, Kei [4 ]
Kawakami, Atsushi [5 ]
Tamura, Maasa [6 ]
Tanino, Yoshinori [7 ]
Nunokawa, Takahiro [8 ]
Kaneko, Yuko [9 ]
Sato, Shinji [10 ]
Asakawa, Katsuaki [11 ]
Nishina, Naoshi [9 ]
Kuwana, Masataka [1 ]
机构
[1] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan
[2] Natl Def Med Coll, Sch Med, Dept Anesthesiol, Tokorozawa, Saitama, Japan
[3] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
[4] Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan
[5] Nagasaki Univ, Div Adv Prevent Med Sci, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, Nagasaki, Japan
[6] Yokohama City Univ, Dept Stem Cell & Immune Regulat, Grad Sch Med, Yokohama, Kanagawa, Japan
[7] Fukushima Med Univ, Dept Pulm Med, Sch Med, Fukushima, Japan
[8] Tokyo Metropolitan Tama Med Ctr, Dept Rheumat Dis, Tokyo, Japan
[9] Keio Univ, Div Rheumatol, Dept Internal Med, Sch Med, Tokyo, Japan
[10] Tokai Univ, Dept Internal Med, Div Rheumatol, Sch Med, Isehara, Kanagawa, Japan
[11] Niigata Univ Med & Dent Hosp, Div Resp Med, Niigata, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 47 条
  • [21] Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies
    Laporte, Amandine
    Mariampillai, Kuberaka
    Allenbach, Yves
    Pasi, Nicoletta
    Donciu, Victoria
    Toledano, Dan
    Granger, Benjamin
    Benveniste, Olivier
    Grenier, Philippe A.
    Boussouar, Samia
    EUROPEAN RADIOLOGY, 2022, 32 (05) : 3480 - 3489
  • [22] Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study
    Chen, F.
    Lu, X.
    Shu, X.
    Peng, Q.
    Tian, X.
    Wang, G.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (06) : 641 - 647
  • [23] Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis
    Shimojima, Yasuhiro
    Ishii, Wataru
    Matsuda, Masayuki
    Kishida, Dai
    Ikeda, Shu-ichi
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (02) : 87 - 93
  • [24] Interstitial Lung Disease And Myositis-Specific And Associated Autoantibodies: Patients Have Similar Clinical Manifestations Although A Heterogeneous Serologic Profile And Prognosis
    Rojas Serrano, J.
    Perez-Roman, D. I.
    Herrera-Bringas, D.
    Castorena-Garcia, P.
    Mejia, M.
    Mateos-Toledo, H.
    Castillo-Pedroza, J.
    Estrada, A.
    Guevara, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [25] Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study
    Ji Su-yun
    Zeng Fan-qin
    Guo Qing
    Tan Guo-zhen
    Tang Hong-feng
    Luo Yi-jin
    Tang Zeng-qi
    Han Yan-fang
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 517 - 522
  • [26] Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease
    Gui, Xianhua
    Li, Wangzhong
    Jiang, Hanyi
    Wang, Rujia
    Yu, Min
    Zhao, Tingting
    Ma, Miao
    Ding, Jingjing
    Jin, Ziyi
    Qiu, Yuying
    Qiu, Xiaohua
    Zhang, Yingwei
    Cao, Min
    Huang, Mei
    Cao, Mengshu
    Dai, Jinghong
    Cai, Hourong
    Xin, Xiaoyan
    Xiao, Yonglong
    RMD OPEN, 2024, 10 (02):
  • [27] Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis
    Hu, Chaojun
    Wu, Chanyuan
    Yang, Enhao
    Huang, Hui
    Xu, Dong
    Hou, Yong
    Zhao, Jiuliang
    Li, Mengtao
    Xu, Zuojun
    Zeng, Xiaofeng
    Wang, Qian
    CLINICAL RHEUMATOLOGY, 2019, 38 (08) : 2181 - 2187
  • [28] Serum KL-6 is associated with the severity of interstitial lung disease in Chinese patients with polymyositis and dermatomyositis
    Chaojun Hu
    Chanyuan Wu
    Enhao Yang
    Hui Huang
    Dong Xu
    Yong Hou
    Jiuliang Zhao
    Mengtao Li
    Zuojun Xu
    Xiaofeng Zeng
    Qian Wang
    Clinical Rheumatology, 2019, 38 : 2181 - 2187
  • [29] Serum Microrna-1 Can be a Predictive Marker for Disease Activity of Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease
    Sugiyama, Yumiko
    Yoshimi, Ryusuke
    Kunishita, Yosuke
    Kishimoto, Daiga
    Kirino, Yohei
    Nakajima, Hideaki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [30] Increased Prevalence of Myositis Specific and Associated Autoantibodies in Patients with Interstitial Lung Disease of Unknown Etiology
    Koulouri, Vasiliki
    Voulgareli, Ilektra
    Flouda, Sofia
    Galanopoulou, Nikoletta
    Marketos, Nikolaos
    Skarlis, Charalampos
    Raftopoulou, Sylvia
    Tavernaraki, Kyriaki
    Chronaiou, Alexia
    Tsoukalas, Georgios
    Zias, Nikolaos
    Boumpas, Dimitrios
    Mavragani, Clio
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2349 - 2351